Adherence to hepatitis A travel health guidelines: A cross-sectional seroprevalence study in Dutch travelling families - The Dutch travel Vaccination Study (DiVeST)
Open Access
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 32, 101511
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The spread of vaccine-preventable diseases by international travellers: a public-health concernClinical Microbiology and Infection, 2012
- Trends in Knowledge, Attitudes, and Practices of Travel Risk Groups Toward Prevention of Hepatitis A: Results From the Dutch Schiphol Airport Survey 2002 to 2009Journal of Travel Medicine, 2012
- Changing risk profile of hepatitis A in The Netherlands: a comparison of seroprevalence in 1995–1996 and 2006–2007Epidemiology and Infection, 2011
- The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccinationJournal of Medical Virology, 2010
- The Risk of Acquiring Hepatitis A and B Among Travelers in Selected Eastern and Southern Europe and Non‐European Mediterranean Countries: Review and Consensus Statement on Hepatitis A and B VaccinationJournal of Travel Medicine, 2007
- Cell mediated and antibody immune response to inactivated hepatitis A vaccineVaccine, 2005
- Detection of antibodies against hepatitis A virus in eluates of blood spotted on filter-paper: a pilot study in Rio de Janeiro, BrazilTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Detection of antibodies against hepatitis A in blood spots dried on filter paper. Is this a reliable method for epidemiological studies?Epidemiology and Infection, 1997
- Current seroepidemiological status of hepatitis A with a comparison of antibody titers after infection and vaccinationJournal of Hepatology, 1994
- Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findingsVaccine, 1992